JO2991B1 - IL-17 Receptor A antigen binding proteins - Google Patents
IL-17 Receptor A antigen binding proteinsInfo
- Publication number
- JO2991B1 JO2991B1 JOP/2007/0407A JOP20070407A JO2991B1 JO 2991 B1 JO2991 B1 JO 2991B1 JO P20070407 A JOP20070407 A JO P20070407A JO 2991 B1 JO2991 B1 JO 2991B1
- Authority
- JO
- Jordan
- Prior art keywords
- receptor
- antigen binding
- binding proteins
- same
- daignosing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided.Aspects of the invention include compositions and methods for daignosing and treating diseases mediated by IL-17 Receptor A activation.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82788206P | 2006-10-02 | 2006-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO2991B1 true JO2991B1 (en) | 2016-09-05 |
Family
ID=41124103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2007/0407A JO2991B1 (en) | 2006-10-02 | 2007-10-02 | IL-17 Receptor A antigen binding proteins |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101541833B (en) |
JO (1) | JO2991B1 (en) |
NO (1) | NO20200595A1 (en) |
UA (1) | UA99716C2 (en) |
ZA (1) | ZA200902018B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201891433A3 (en) * | 2010-01-15 | 2019-02-28 | Кирин-Эмджен, Инк. | COMPOSITION ANTIBODIES AND THERAPEUTIC REGIMES |
EP3757126A1 (en) * | 2010-11-05 | 2020-12-30 | Novartis AG | Methods of treating psoriatic arthritis using il-17 antagonists |
KR102530900B1 (en) * | 2014-03-31 | 2023-05-12 | 암젠 케이-에이, 인크. | Methods of treating nail and scalp psoriasis |
AU2015307868B2 (en) * | 2014-08-26 | 2020-08-27 | Amgen K-A, Inc. | Method for treating psoriasis patient which received anti-TNF-alpha antibody therapy |
CN110003337B (en) * | 2019-04-12 | 2023-05-09 | 深圳普瑞金生物药业股份有限公司 | IL17RA single domain antibody, nucleic acid and kit |
CN112891530B (en) * | 2020-06-19 | 2021-08-24 | 北京东方百泰生物科技股份有限公司 | Injection preparation of anti-IL-17 RA monoclonal antibody |
CN113150149B (en) * | 2020-06-19 | 2021-10-08 | 北京东方百泰生物科技股份有限公司 | Purification method of anti-IL-17 RA monoclonal antibody |
CN111848795B (en) * | 2020-06-19 | 2021-03-12 | 北京东方百泰生物科技股份有限公司 | anti-IL-17 RA monoclonal antibody and application thereof |
CN113896793B (en) * | 2021-09-30 | 2023-05-26 | 港科鹏禾生物(苏州)有限公司 | Monoclonal antibody for resisting human IL-17RC and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0608210A2 (en) * | 2005-02-14 | 2010-11-09 | Wyeth Corp | methods of diagnosing an il-17f-related disorder in an individual and selecting compounds capable of inhibiting il-17f binding in il-17r, use of an il-17f antagonist, pharmaceutical composition, and vaccine adjuvant |
-
2007
- 2007-10-01 CN CN200780043254.XA patent/CN101541833B/en active Active
- 2007-10-01 UA UAA200904215A patent/UA99716C2/en unknown
- 2007-10-02 JO JOP/2007/0407A patent/JO2991B1/en active
-
2009
- 2009-03-23 ZA ZA200902018A patent/ZA200902018B/en unknown
-
2020
- 2020-05-19 NO NO20200595A patent/NO20200595A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA99716C2 (en) | 2012-09-25 |
CN101541833A (en) | 2009-09-23 |
ZA200902018B (en) | 2010-07-28 |
NO20200595A1 (en) | 2009-06-30 |
CN101541833B (en) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2991B1 (en) | IL-17 Receptor A antigen binding proteins | |
EA201000238A1 (en) | ANTIGEN-BINDING PROTEINS FOR IL-18 RECEPTOR AND THEIR APPLICATION | |
NZ592432A (en) | Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1) | |
PH12015501848A1 (en) | Binding agents | |
UA102867C2 (en) | Anti cxcr4 antibodies and their use for the treatment of cancer | |
WO2009041832A3 (en) | Vaccines and vaccine components for inhibition of microbial cells | |
MY162624A (en) | Antibodies directed to her-3 and uses thereof | |
MX2009003511A (en) | Il-17 receptor a antigen binding proteins. | |
CA2813849C (en) | Secukinumab for use in the treatment of ankylosing spondylitis | |
WO2014089335A3 (en) | Bcma antigen binding proteins | |
MX348360B (en) | CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY. | |
MX2010005022A (en) | Antibodies that bind human dendritic and epithelial cell 205 (dec-205). | |
MY174493A (en) | Binding agents | |
UA97516C2 (en) | Fully human anti-vap-1 monoclonal antibody | |
MX2012007340A (en) | Anti-her3 antibodies and uses thereof. | |
EA201790757A1 (en) | BONDING ANTIGEN CD27L PROTEINS | |
MX2011003502A (en) | Cross-species-specific psmaxcd3 bispecific single chain antibody. | |
WO2007067992A3 (en) | Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 | |
WO2006089230A3 (en) | Human monoclonal antibodies to prostate specific membrane antigen (psma) | |
TN2011000528A1 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
AU2009260320A8 (en) | Antibodies to IL-6 and their uses | |
MX2011009220A (en) | Fully human antibodies specific to cadm1. | |
MX2011012039A (en) | Blocking anti-dkk-1 antibodies and their uses. | |
UA105073C2 (en) | Anti-fractalkine antibody, composition and method for treating inflammatory disorders | |
MX2010001237A (en) | Novel antibodies. |